These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 29101034)
21. MeCP2 nuclear dynamics in live neurons results from low and high affinity chromatin interactions. Piccolo FM; Liu Z; Dong P; Hsu CL; Stoyanova EI; Rao A; Tjian R; Heintz N Elife; 2019 Dec; 8():. PubMed ID: 31868585 [TBL] [Abstract][Full Text] [Related]
22. An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Baker SA; Chen L; Wilkins AD; Yu P; Lichtarge O; Zoghbi HY Cell; 2013 Feb; 152(5):984-96. PubMed ID: 23452848 [TBL] [Abstract][Full Text] [Related]
23. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin. Hansen JC; Ghosh RP; Woodcock CL IUBMB Life; 2010 Oct; 62(10):732-8. PubMed ID: 21031501 [TBL] [Abstract][Full Text] [Related]
24. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA. Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833 [TBL] [Abstract][Full Text] [Related]
26. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. Buschdorf JP; Strätling WH J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241 [TBL] [Abstract][Full Text] [Related]
27. MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites. Ghosh RP; Horowitz-Scherer RA; Nikitina T; Shlyakhtenko LS; Woodcock CL Mol Cell Biol; 2010 Oct; 30(19):4656-70. PubMed ID: 20679481 [TBL] [Abstract][Full Text] [Related]
28. A/T Run Geometry of B-form DNA Is Independent of Bound Methyl-CpG Binding Domain, Cytosine Methylation and Flanking Sequence. Chia JY; Tan WS; Ng CL; Hu NJ; Foo HL; Ho KL Sci Rep; 2016 Aug; 6():31210. PubMed ID: 27502833 [TBL] [Abstract][Full Text] [Related]
29. Disruption of AT-hook 1 domain in MeCP2 protein caused behavioral abnormality in mice. Xu M; Song P; Huang W; He R; He Y; Zhou X; Gu Y; Pan S; Hu Y Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):347-358. PubMed ID: 29074463 [TBL] [Abstract][Full Text] [Related]
30. Unique physical properties and interactions of the domains of methylated DNA binding protein 2. Ghosh RP; Nikitina T; Horowitz-Scherer RA; Gierasch LM; Uversky VN; Hite K; Hansen JC; Woodcock CL Biochemistry; 2010 May; 49(20):4395-410. PubMed ID: 20405910 [TBL] [Abstract][Full Text] [Related]
32. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996 [TBL] [Abstract][Full Text] [Related]
33. The solution structure of the domain from MeCP2 that binds to methylated DNA. Wakefield RI; Smith BO; Nan X; Free A; Soteriou A; Uhrin D; Bird AP; Barlow PN J Mol Biol; 1999 Sep; 291(5):1055-65. PubMed ID: 10518942 [TBL] [Abstract][Full Text] [Related]
34. Biophysical analysis and small-angle X-ray scattering-derived structures of MeCP2-nucleosome complexes. Yang C; van der Woerd MJ; Muthurajan UM; Hansen JC; Luger K Nucleic Acids Res; 2011 May; 39(10):4122-35. PubMed ID: 21278419 [TBL] [Abstract][Full Text] [Related]
35. Rett syndrome-causing mutations in human MeCP2 result in diverse structural changes that impact folding and DNA interactions. Ghosh RP; Horowitz-Scherer RA; Nikitina T; Gierasch LM; Woodcock CL J Biol Chem; 2008 Jul; 283(29):20523-34. PubMed ID: 18499664 [TBL] [Abstract][Full Text] [Related]
36. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881 [TBL] [Abstract][Full Text] [Related]
37. MeCP2 post-translational regulation through PEST domains: two novel hypotheses: potential relevance and implications for Rett syndrome. Thambirajah AA; Eubanks JH; Ausió J Bioessays; 2009 May; 31(5):561-9. PubMed ID: 19319913 [TBL] [Abstract][Full Text] [Related]
38. Regulation mechanism and research progress of MeCP2 in Rett syndrome. Yang W; Pan H Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025 [TBL] [Abstract][Full Text] [Related]
39. Impaired in vivo binding of MeCP2 to chromatin in the absence of its DNA methyl-binding domain. Stuss DP; Cheema M; Ng MK; Martinez de Paz A; Williamson B; Missiaen K; Cosman JD; McPhee D; Esteller M; Hendzel M; Delaney K; Ausió J Nucleic Acids Res; 2013 May; 41(9):4888-900. PubMed ID: 23558747 [TBL] [Abstract][Full Text] [Related]
40. Mecp2-null mice provide new neuronal targets for Rett syndrome. Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]